Market Research Reports

Explore our extensive library of 3886 market intelligence reports.

Showing 551 - 560 of 3886 reports

Visceral Leishmaniasis Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 612.4 million Market Size 2034: USD 1,104.7 million CAGR: 6.1% Market Definition: The visceral leishmaniasis market encompasses diagnostics, therapeutics, and vector control products targeting the systemic form of leishmaniasis caused by Leishmania donovani and L. infantum, transmitted via Phlebotomus … Read More
Published June 2026

Vinflunine Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 312.6 Million Market Size 2034: USD 498.4 Million CAGR: 4.8% Market Definition: Vinflunine is a third-generation fluorinated vinca alkaloid used primarily as a second-line treatment for advanced or metastatic transitional cell carcinoma of the urothelial tract. The market encompasses … Read More
Published June 2026

Yaws Disease Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 185.4 million Market Size 2034: USD 412.7 million CAGR: 8.3% Market Definition: The yaws disease market encompasses diagnostics, therapeutics, and public health intervention programs targeting Treponema pallidum pertenue infection, a neglected tropical disease affecting skin, bone, and cartilage primarily … Read More
Published June 2026

Vestibular Neuronitis Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.42 Billion Market Size 2034: USD 2.61 Billion CAGR: 6.3% Market Definition: The vestibular neuronitis treatment market encompasses pharmaceuticals, vestibular rehabilitation therapies, and diagnostic services used to manage acute vertigo and balance dysfunction caused by vestibular nerve inflammation. It … Read More
Published June 2026

Venlafaxine Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.84 billion Market Size 2034: USD 3.12 billion CAGR: 5.4% Market Definition: The venlafaxine market encompasses the global manufacture, distribution, and sale of venlafaxine hydrochloride in immediate-release and extended-release formulations. It includes branded and generic products used in the … Read More
Published June 2026

Vasovagal Syncope Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.82 billion Market Size 2034: USD 3.41 billion CAGR: 6.5% Market Definition: The vasovagal syncope treatment market encompasses pharmacological agents, implantable devices, and non-pharmacological interventions used to prevent and manage reflex-mediated fainting episodes triggered by autonomic nervous system dysfunction. … Read More
Published June 2026

Zollinger Ellison Syndrome Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.84 billion Market Size 2034: USD 3.12 billion CAGR: 5.4% Market Definition: The Zollinger-Ellison Syndrome (ZES) treatment market encompasses pharmaceutical and surgical interventions targeting gastrin-secreting tumors (gastrinomas) and their associated hypersecretory acid conditions. It includes proton pump inhibitors, somatostatin … Read More
Published June 2026

Animal Anti-Rabies Vaccine Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.82 billion Market Size 2034: USD 3.41 billion CAGR: 6.5% Market Definition: The animal anti-rabies vaccine market encompasses biological products designed to immunise domestic animals, livestock, and wildlife against the rabies virus. It includes inactivated, live-attenuated, and recombinant vaccine … Read More
Published June 2026

X-Linked Hypophosphatemia (XLH) Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $1.84 billion Market Size 2034: $4.12 billion CAGR: 8.4% Market Definition: The XLH treatment market encompasses pharmaceutical therapies, including FGF23-inhibiting biologics and conventional phosphate-vitamin D supplementation regimens, used to manage X-Linked Hypophosphatemia, a rare hereditary phosphate-wasting disorder caused by PHEX … Read More
Published June 2026

Sickle Cell Disease Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 3.8 Billion Market Size 2034: USD 12.6 Billion CAGR: 12.7% Market Definition: The sickle cell disease market encompasses therapeutics, gene therapies, and supportive care products developed to treat or cure SCD, a hereditary hemoglobin disorder causing red blood cell … Read More
Published June 2026